AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparison of Outcomes of Management of Bowel Obstruction

RecruitingPhase 4Ages 18 Years - anyAllUniversity of Washington
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The Comparison of Outcomes of Management of Bowel Obstruction (COMBO) trial is a patient-level randomized trial of a short course of dexamethasone + supportive care vs supportive care alone for patients with adhesion-related small bowel obstruction (aSBO). The goal of the COMBO trial is to answer the question: Can Dexamethasone increases the proportion of patients with resolution of aSBO with non-operative management (without complication) based on an established minimal important clinical difference.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults โ‰ฅ18 years of age recruited from UWMC * Patients presenting to surgical services through the Emergency Department, diagnosis of SBO, consulted by surgeon, and an urgent or emergency operation is deemed not necessary by surgeon. * Diagnosis of aSBO is established by; 1. CT findings consistent with diagnosis of SBO; and 2. signs and symptoms consistent with SBO; and 3. Adhesions from prior abdominopelvic surgery are the likely cause of SBO (absence of incarcerated hernia, internal hernia, masses, fistula, stricture, volvulus, acute episode of inflammatory bowel disease (IBD) flare, etc.). * Ability to provide written or electronic informed consent in English and answer teach-back questions Exclusion Criteria: * Signs and symptoms of peritonitis with emergency operation planned * Planned urgent operation within the next 12 hours * Allergy to dexamethasone * Surgery within prior 6 weeks * Unable or unwilling to return or be contacted for and/or complete research surveys * Currently incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening * Individuals with latent infections who have an increased risk of infection.
๐Ÿ’Š

What it tests

  • Dexamethasone
  • Supportive Care
๐Ÿ“

Where

4 sites
Columbia University Medical Center
New York, United States
Harborview Medical Center
Seattle, United States
UW Medical Center - Northwest
Seattle, United States
University of Washington Medical Center Montlake
Seattle, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy